Announcements Trials
Browse Landscape

Status

Available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 10Expanded_access 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasm Malignant Female 1

Interventions

veliparib 2tucatinib 2leronlimab 2abemaciclib 2Trastuzumab 2Capecitabine 2Alpelisib 2zenocutuzumab 1selpercatinib 1sacituzumab govitecan 1ribociclib 1pertuzumab 1pegilodecakin 1palbociclib 1margetuximab 1iniparib 1glembatumumab vedotin 1gedatolisib 1eribulin 1Vinorelbine 1Proton Pump Inhibitors 1Letrozole 1Lapatinib 1Hydrocortisone 1Everolimus 1Cisplatin 1Ado-Trastuzumab Emtansine 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × gedatolisib × Breast × Clear all
NCT05134922 2025-03-21

Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009

Celcuity Inc

Available
Breast

Breast Neoplasm Malignant Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡